Spectrum Pharmaceuticals

Spectrum bags cancer drugs, interferon platform from ImmunGene
Spectrum bags cancer drugs, interferon platform from ImmunGene
Fierce Biotech
Spectrum Pharmaceuticals
ImmunGene
drug development
interferon
Flag link:
Spectrum yanks marketing application for Neulasta rival after FDA demands more data
Spectrum yanks marketing application for Neulasta rival after FDA demands more data
Endpoints
Spectrum Pharmaceuticals
FDA
lung cancer
poziotinib
Neulasta
Flag link:
Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia
Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia
CP Wire
Spectrum Pharmaceuticals
Rolontis
neutropenia
Flag link:
Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia
Spectrum Pharmaceuticals
Flag link:
Spectrum Pharma Is Weighing a Sale
Spectrum Pharma Is Weighing a Sale
Bloomberg
Spectrum Pharmaceuticals
M&A
Flag link:
3 Biotech Stocks That Soared This Week
3 Biotech Stocks That Soared This Week
Motley Fool
AveXis
Abeona Therapeutics
Spectrum Pharmaceuticals
Novartis
M&A
poziotinib
EB-101
Flag link:
3 Biotech Stocks to Be Thankful for This Year
3 Biotech Stocks to Be Thankful for This Year
Yahoo/Motley Fool
biotech
Loxo Oncology
Nektar
Spectrum Pharmaceuticals
Flag link:
3 Biotech Stocks That Soared This Week: Are They Buys?
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
biotech
Madrigal Pharmaceuticals
Spectrum Pharmaceuticals
poziotinib
ZX008
Zogenix
Flag link:
Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee
Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee
Marketwatch
Spectrum Pharmaceuticals
FDA
Qapzola
cancer
Flag link:
Spectrum's once-rejected cancer drug wins FDA approval
Spectrum's once-rejected cancer drug wins FDA approval
Fierce Biotech
Spectrum Pharmaceuticals
FDA
Evomela
Flag link:
Spectrum Pharmaceuticals reports 3rd-quarter loss but tops expectations
Spectrum Pharmaceuticals reports 3rd-quarter loss but tops expectations
Yahoo/AP
Spectrum Pharmaceuticals
earnings
Flag link:
Spectrum says U.S. FDA declines to approve Evomela for injection
Spectrum says U.S. FDA declines to approve Evomela for injection
Yahoo/Reuters
FDA
Spectrum Pharmaceuticals
Evomela
Multiple Myeloma
Flag link:
Two Biotechs Worth A Look Ahead Of FDA Approvals
Two Biotechs Worth A Look Ahead Of FDA Approvals
Investopedia
FDA
BioDelivery Sciences
Belbuca
chronic pain
Spectrum Pharmaceuticals
Evomela
Flag link:
Bam! Bam! Two Plaintiffs Fall in Two District Court Decisions Concerning Orphan Drug Exclusivity Carve-Outs
Bam! Bam! Two Plaintiffs Fall in Two District Court Decisions Concerning Orphan Drug Exclusivity Carve-Outs
FDA Law Blog
Otsuka
Abilify
orphan drugs
exclusivity
Fusilev
Spectrum Pharmaceuticals
Flag link:
It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions
It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions
FDA Law Blog
FDA
Hatch Waxman Act
Spectrum Pharmaceuticals
Boehringer Ingelheim
Otsuka
Flag link:
Spectrum Pharma reports 4Q loss
Spectrum Pharma reports 4Q loss
Yahoo/AP
Spectrum Pharmaceuticals
earnings
Flag link:
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Flag link:
Spectrum submits blood-cancer drug for FDA approval
Spectrum submits blood-cancer drug for FDA approval
Marketwatch
Spectrum Pharmaceuticals
FDA
CE-Melphalan
Multiple Myeloma
Ligand Pharmaceuticals
Flag link:
FDA approves Spectrum Pharma's blood cancer drug
FDA approves Spectrum Pharma's blood cancer drug
Yahoo/Reuters
FDA
Spectrum Pharmaceuticals
Beleodaq
peripheral T-cell lymphoma
Flag link:
Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play
Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play
Forbes
Spectrum Pharmaceuticals
Flag link:

Pages